PES-HORISONT-EU-PES Horisont Europa
A new biomarker system for early diagnosis and management of Alzheimer Disease
For the first time in 20 years, new Alzheimer disease (AD) drugs are entering the market. Thus, methods that reliably detect AD early, help to diagnose patients non-invasively and predict response to these treatments will be essential in the near future. With this in mind, Pre Diagnostics has dev...